NPAM Education Session: What Ambulatory Care Providers Need to Know: Immune-related Adverse Events (irAEs) Associated with Immune Checkpoint Inhibitors
April 16 @ 7:30 pm - 8:30 pm
7:30 pm
Dr. Mark Kristjanson, CCFP
Primary Care in Oncology, Urgent Cancer Care Lead
*Virtual Session*
By the end of the session, the participant will be able to
- Describe clinical presentations that might represent immune-related adverse events (irAEs) from immune checkpoint inhibitors
- Explain the grading system for irAEs
- Describe the lab and imaging workup of suspected skin, gut, endocrine, liver or lung irAEs
- Collaborate with medical oncologists and other specialists in the management of irAEs.
Speaker Bio:
Dr. Kristjanson graduated from the Faculty of Medicine in 1985 and pursued a one-year rotating internship with Manitoba Affiliated Teaching Hospitals. He has practiced in Stonewall, MB from 1988 to 1995 in solo and group private practices before returning to Winnipeg to practice with the McPhillips Medical Group. In 2003 he accepted a teaching position with the University of Manitoba’s Family Medicine residency program and taught at the Kildonan Medical Center until 2012. In 2012 Dr. Kristjanson obtained privileges to attend at St. Amant’s River Road Place (now Health & Transition Services) where he continues to round weekly on long-term residents with severe and profound developmental disabilities.
Dr. Kristjanson served as Medical Lead for Primary Care in CancerCare Manitoba’s Community Oncology Program from October 2013 until May 2022. He works part-time in CancerCare’s Urgent Cancer Care clinic and has done so since UCC’s inception in November 2013. He continues to enjoy greatly the privilege of serving as preceptor for learners in the University of Manitoba’s Family Medicine, Internal Medicine, and Nurse Practitioner programs when, from time to time, they join him for a clinical exposure in Urgent Cancer Care.
Dr. Kristjanson has a number of research interests including the effect of steroid-induced hyperglycemia on outcomes of chemotherapy for lymphoma. He served as principal investigator for a retrospective study on this topic.
Kristjanson M, Lambert P, Decker KM, Bruin S, Tingey E, Skrabek P. Steroid-Induced Hyperglycemia and Its Effect on Outcomes of R-CHOP Chemotherapy for Diffuse Large B-Cell Lymphoma. Curr. Oncol. 2023, 30(12), 10142-10151; https://doi.org/10.3390/curroncol30120738
Dr. Kristjanson has collaborated in several more research studies involving cancer survival and outcomes of intellectually disabled adults.
We are thrilled to have such an accomplished and distinguished lecturer educating us in oncology!